Eric Kelsic, Dyno Therapeutics CEO
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
Adeno-associated viruses (AAV) for gene therapy have received a ton of scrutiny throughout the field’s history after a smattering of safety scares and their limited …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.